Faster relief for thyroid cancer patients? study tests new medication combo
NCT ID NCT06647602
Summary
This study aims to find the best way to restart thyroid hormone medication after treatment for high-risk thyroid cancer. Researchers will compare two approaches: a standard single hormone versus a combination of two hormones. They want to see which helps patients feel better faster and more effectively controls hormone levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radboud University Nijmegen
Nijmegen, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Medical Center Groningen (UMCG)
Groningen, Provincie Groningen, 9700RB, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.